Trinity Biotech (TRIB) Return on Sales (2016 - 2025)
Historic Return on Sales for Trinity Biotech (TRIB) over the last 17 years, with Q2 2025 value amounting to 13.55%.
- Trinity Biotech's Return on Sales rose 139900.0% to 13.55% in Q2 2025 from the same period last year, while for Jun 2025 it was 13.55%, marking a year-over-year increase of 139300.0%. This contributed to the annual value of 0.01% for FY2024, which is 2400.0% down from last year.
- Latest data reveals that Trinity Biotech reported Return on Sales of 13.55% as of Q2 2025, which was up 139900.0% from 1.02% recorded in Q4 2024.
- In the past 5 years, Trinity Biotech's Return on Sales ranged from a high of 13.55% in Q2 2025 and a low of 1.34% during Q2 2023
- Over the past 5 years, Trinity Biotech's median Return on Sales value was 0.43% (recorded in 2023), while the average stood at 0.36%.
- Its Return on Sales has fluctuated over the past 5 years, first crashed by -10200bps in 2022, then surged by 139900bps in 2025.
- Quarter analysis of 5 years shows Trinity Biotech's Return on Sales stood at 0.18% in 2021, then plummeted by -282bps to 0.69% in 2022, then soared by 40bps to 0.41% in 2023, then plummeted by -149bps to 1.02% in 2024, then soared by 1428bps to 13.55% in 2025.
- Its last three reported values are 13.55% in Q2 2025, 1.02% for Q4 2024, and 0.32% during Q3 2024.